Detection of SARS-CoV-2 RNA in nasopharyngeal swabs from COVID-19 patients and asymptomatic cases of infection by real-time and digital PCR.

Обнаружение РНК SARS-CoV-2 в носоглоточных мазках больных COVID-19 и бессимптомных носителей методами цифровой ПЦР и ПЦР в реальном времени.

Journal

Klinicheskaia laboratornaia diagnostika
ISSN: 0869-2084
Titre abrégé: Klin Lab Diagn
Pays: Russia (Federation)
ID NLM: 9432021

Informations de publication

Date de publication:
29 Dec 2020
Historique:
entrez: 29 12 2020
pubmed: 30 12 2020
medline: 1 1 2021
Statut: ppublish

Résumé

In this work we tested two reagent kits developed by us for detecting SARS-CoV-2 RNA using a fragment of the ORF1ab gene in digital PCR and real-time PCR formats. Data were obtained on the detection of SARS-CoV-2 virus RNA in nasopharyngeal swabs of patients with COVID-19 and asymptomatic carriers. The developed reagent kits provided 100% sensitivity and a detection limit of 103 GE / ml for qPCR, and at least 200 copies / ml of viral RNA when performing digital PCR. These methods were tested using a panel of 1,328 samples collected from patients with suspected COVID-19 at the beginning of 2020 in the Russian Federation. It has been shown that dPCR is more sensitive and can be used to analyze samples with low viral load, including those from patients without clinical symptoms. dPCR significantly improves the accuracy of laboratory research and significantly reduces the number of false negative results in the diagnosis of SARS-CoV-2. Determination of the concentration of SARS-CoV-2 RNA in patients with different clinical course of the disease showed that the concentration of viral RNA can sharply decrease in the first days of the disease. A low concentration of viral RNA in samples from patients is also characteristic of asymptomatic disease. Digital PCR provides a higher detection rate for asymptomatic cases, which is approximately 75% of those infected, as opposed to 45% for real-time PCR. The results obtained on the use of the digital PCR method for detecting SARS-CoV-2 RNA showed that this method is especially suitable for detecting RNA in case of its low concentration in contacts, as well as for monitoring changes in viral load in convalescent patients.

Identifiants

pubmed: 33373511
doi: 10.18821/0869-2084-2020-65-12-785-792
doi:

Substances chimiques

RNA, Viral 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

785-792

Déclaration de conflit d'intérêts

The authors declare no conflict of interest.

Références

Zhu N., Zhang D., Wang W. A novel coronavirus from patients with pneumonia in China, 2019. N. Engl. J. Med. 2020; 382:727–33.
Walls A.C., Park Y.J., Tortorici M.A., Wall A., McGuire A.T., Veesler D. Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein. Cell. 2020; 181(2):281-92.e6. doi: 10.1016/j.cell.2020.02.058. Epub 2020 Mar 9.
Qiu F., Wang H., Zhang Z., Cao L., Wang C., Wu J., Du Q. Laboratory testing techniques for SARS-CoV-2. Nan Fang Yi Ke Da Xue Xue Bao. 2020; 40(2):164-7. doi: 10.12122/j.issn.1673-4254.2020.02.04.
Tao Zhang, Qunfu Wu, Zhigang Zhang. Probable Pangolin Origin of SARS-CoV-2 Associated With the COVID-19 Outbreak. Curr. Biol. 2020;30 (7): 1346-51.
Hoffmann M., Kleine-Weber H., Pöhlmann S. A Multibasic Cleavage Site in the Spike Protein of SARS-CoV-2 Is Essential for Infection of Human Lung Cells. Molecular Cell. 2020; DOI: 10.1016/j.molcel.2020.04.022.
Zhai P., Ding Y., Wu X., Long J., Zhong Y., Li Y. The epidemiology, diagnosis and treatment of COVID-19. Int. J. Antimicrob. Agents. 2020 May;55(5):105955. doi: 10.1016/j.ijantimicag.2020.105955. Epub 2020 Mar 28. PMID: 32234468.
https://jamanetwork.com/journals/jama/fullarticle/2765837?guestAccessKey=61b73a23-25e1-46bd-96c5-cf0ec847df25&utm_source=twitter&utm_medium=social_ jama&utm_term=3324078795&utm_campaign=article_alert&linkId=88064719.
Quan P-L., Sauzade M., Brouzes E. dPCR: A Technology Review Sensors (Basel). 2018 Apr; 18(4): 1271. Published online 2018 Apr 20. doi: 10.3390/s18041271.
Hindson B.J., Ness K.D., Masquelier D.A., Belgrader P., Heredia N.J., Makarewicz A.J. et al. High-throughput droplet digital PCR system for absolute quantitation of DNA copy number. Anal. Chem . 2011;83: 8604-10.
Hindson C.M., Chevillet J.R., Briggs H.A., Gallichotte E.N., Ruf I.K., Hindson B.J. et al. Absolute quantification by droplet digital PCR versus analog real-time PCR. Nature methods . 2013;10:1003-5.
Vogelstein B., Kinzler K.W. Digital pcr. Proc. Natl. Acad. Sci USA. 1999; 96:9236-41.
Dingle T.C., Sedlak R.H., Cook L., Jerome K.R. Tolerance of droplet-digital PCR VS real-time quantitative PCR to inhibitory substances. Clinical chemistry. 2013;59:1668-70.
Sergeeva E.I., Ternovoi V.A., Agafonov A.P., Sergeev A.N. A set of oligodeoxyribonucleotide primers and fluorescently labeled probes for the identification of RNA of coronaviruses 229E, NL63, OC43, HKU1 by hybridization-fluorescent reverse transcriptase polymerase chain reaction. Patent RF № 2473702; 2011. (in Russian)
Li Y.C., Bai W.Z., Hashikawa T. The neuroinvasive potential of SARS-CoV2 may play a role in the respiratory failure of COVID-19 patients. J. Med. Virol. 2020 Jun; 92(6):552-5. doi: 10.1002/jmv.25728. Epub 2020 Mar 11.
Madabhavi I., Sarkar M., Kadakol N. COVID-19: a review. Monaldi Arch. Chest. Dis. 2020 May 14; 90(2). doi: 10.4081/monaldi.2020.1298. PMID: 32498503.
Singhal T. A Review of Coronavirus Disease-2019 (COVID-19). Indian J. Pediatr. 2020 Apr;87(4):281-6. doi: 10.1007/s12098-020-03263-6. Epub 2020 Mar 13. PMID: 32166607.
Tian S., Hu W., Niu L., Liu H., Xu H., Xiao S.Y. Pulmonary Pathology of Early-Phase 2019 Novel Coronavirus (COVID-19) Pneumonia in Two Patients With Lung Cancer. J. Thorac. Oncol. 2020 May;15(5):700-4. doi: 10.1016/j.jtho.2020.02.010. Epub 2020 Feb 28. PMID: 32114094.
Sergeeva E.I., Ternovoy V.A., Agafonov A.P., Sergeev A.N. A set of oligodeoxyribonucleotide primers and a fluorescent-labeled probe for the identification of RNA of human coronavirus associated with severe acute respiratory syndrome. Patent RF № 2504585; 2012. (in Russian)
Sergeeva E.I., Ternovoy V.A., Demina O.K., Demina A.V., Korneev D.V. et al. Development and verification of real-time PCR assay for identification of viral agents causing acute respiratory infections in human beings. Molekulyarnaya genetika, mikrobiologiya I virusologiya. 2013 October; 28(4): 32-7. DOI: 10.3103/S0891416813040083. (in Russian)
Wu Y., Strain M.C., Lada S.M., Luong T., Rought S.E., Gianella S., et al. Highly precise measurement of HIV DNA by droplet digital PCR. PLoS ONE. 2013; 8:e55943.
Daniel W.T., Kristian L. M.D., Marina K., David A.A., Patricia E.G., Robert L.J. et al. Protocols for determination of limits of detection and limits of quantitation; approved guideline. CLSI EP17-A; 24(34).
Huggett J.F., Foy C.A., Benes V., Emslie K, Garson J.A., Haynes R. et al. The digital MIQE guidelines: Minimum Information for Publication of Quantitative Digital PCR Experiments. Clinical Chemistry. 2013;59:892-902.
Weaver S., Dube S., Mir A., Qin J., Sun G., Ramakrishnan R. Taking qPCR to a higher level: Analysis of CNV reveals the power of high throughput qPCR to enhance quantitative resolution. Methods. 2010;50:271-6.
He X., Lau E.H.Y., Wu P., Deng X., Wang J., Hao X., et al. Temporal dynamics in viral shedding and transmissibility of COVID-19. Nat. Med. (2020). https://doi.org/10.1038/s41591-020-0869-5
Yang Y., Yang M., Shen C., Wang F., Yuan J., Li J. et al. Evaluating the accuracy of different respiratory specimens in the laboratory diagnosis and monitoring the viral shedding of 2019-nCOV infections. MedRxiv 2020.02.11.20021493. https://doi.Org/10.1101/2020.02.11.20021493.
Rothe C., Schunk M., Sothmann P., Bretzel G., Froeschl G., Wallrauch C., et al. Transmission of 2019-nCoV Infection 245 from an Asymptomatic Contact in Germany. N. Engl. J. Med. 2020. DOI: 10.1056/NEJMc2001468.
Lianhua Dong, Junbo Zhou,Chunyan Niu, Quanyi Wang, Yang Pan, Xia Wang et al. Highly accurate and sensitive diagnostic detection of SARS-CoV-2 by digital PCR. medRxiv 2020.03.14.20036129; DOI: 10.1101/2020.03.14.20036129.
Ai T., Yang Z., Hou H., Zhan C., Chen C., Lv W. et al. Correlation of chest Ct and RT-PCR testing in coronavirus disease 2019 (COVID-19) in China: A report of 1014 cases. Radiology. 2020:200642.
Whale A.S., Jones G.M., Jernej P., Dreo T., Redshaw N., Akyürek S. et al. Assessment of digital PCR as a primary reference measurement procedure to support advances in precision medicine. Clinical Chemistry. 2018;64:1296-307.
Lauer S.A., Grantz K.H., Bi Q., Jones F.K., Zheng Q., Meredith H.R. et al. The Incubation Period of Coronavirus Disease 2019 (COVID-19) From Publicly Reported Confirmed Cases: Estimation and Application. Ann. Intern. Med. 2020 May 5;172(9): 577-82. doi: 10.7326/M20-0504. Epub 2020 Mar 10.

Auteurs

V A Ternovoi (VA)

State Research Center of Virology and Biotechnology VECTOR, World-class Genomic Research Center for Ensuring Biological Safety and Technological Independence within the framework of the Federal Scientific and Technical Program for the Development of Genetic Technologies.

R Yu Lutkovsky (RY)

State Research Center of Virology and Biotechnology VECTOR, World-class Genomic Research Center for Ensuring Biological Safety and Technological Independence within the framework of the Federal Scientific and Technical Program for the Development of Genetic Technologies.

E P Ponomareva (EP)

State Research Center of Virology and Biotechnology VECTOR, World-class Genomic Research Center for Ensuring Biological Safety and Technological Independence within the framework of the Federal Scientific and Technical Program for the Development of Genetic Technologies.

A V Gladysheva (AV)

State Research Center of Virology and Biotechnology VECTOR, World-class Genomic Research Center for Ensuring Biological Safety and Technological Independence within the framework of the Federal Scientific and Technical Program for the Development of Genetic Technologies.

E V Chub (EV)

State Research Center of Virology and Biotechnology VECTOR, World-class Genomic Research Center for Ensuring Biological Safety and Technological Independence within the framework of the Federal Scientific and Technical Program for the Development of Genetic Technologies.

N L Tupota (NL)

State Research Center of Virology and Biotechnology VECTOR, World-class Genomic Research Center for Ensuring Biological Safety and Technological Independence within the framework of the Federal Scientific and Technical Program for the Development of Genetic Technologies.

A M Smirnova (AM)

State Research Center of Virology and Biotechnology VECTOR, World-class Genomic Research Center for Ensuring Biological Safety and Technological Independence within the framework of the Federal Scientific and Technical Program for the Development of Genetic Technologies.

A A Nazarenko (AA)

State Research Center of Virology and Biotechnology VECTOR, World-class Genomic Research Center for Ensuring Biological Safety and Technological Independence within the framework of the Federal Scientific and Technical Program for the Development of Genetic Technologies.

V B Loktev (VB)

State Research Center of Virology and Biotechnology VECTOR, World-class Genomic Research Center for Ensuring Biological Safety and Technological Independence within the framework of the Federal Scientific and Technical Program for the Development of Genetic Technologies.

E V Gavrilova (EV)

State Research Center of Virology and Biotechnology VECTOR, World-class Genomic Research Center for Ensuring Biological Safety and Technological Independence within the framework of the Federal Scientific and Technical Program for the Development of Genetic Technologies.

A P Agafonov (AP)

State Research Center of Virology and Biotechnology VECTOR, World-class Genomic Research Center for Ensuring Biological Safety and Technological Independence within the framework of the Federal Scientific and Technical Program for the Development of Genetic Technologies.

R A Maksyutov (RA)

State Research Center of Virology and Biotechnology VECTOR, World-class Genomic Research Center for Ensuring Biological Safety and Technological Independence within the framework of the Federal Scientific and Technical Program for the Development of Genetic Technologies.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH